South Rampart Pharma Expands Global Patent Portfolio with EU Approval for FDA Fast-Tracked SRP-001 for Pain
November 1, 2023 South Rampart’s Global Intellectual Property Portfolio Now
November 1, 2023 South Rampart’s Global Intellectual Property Portfolio Now
Oct. 12, 2023 The Fast Track designation accelerates SRP-001's path
October 10, 2023 - BIO Investor Forum taking place on
Sept. 21, 2023 The NIH's CRP Award Further Validates the
August 22, 2023 - SRP-001, a novel, non-opioid investigational drug
July 6, 2023 South Rampart's global intellectual property portfolio now
Jan. 31, 2023 Hernan Bazan, MD, FACS, CEO and Co-Founder,
Oct. 21, 2022 South Rampart Pharma ("South Rampart" or the
Oct. 4, 2022 - New patent grant further secures South Rampart's
Sept. 22, 2022 South Rampart Pharma ("South Rampart" or the